Effects of quetiapine on cognitive functioning in obsessive???compulsive disorder
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
In recent years, growing evidence supports the efficacy of antipsychotic addition to serotonin reuptake inhibitors in patients with treatment-refractory obsessive-compulsive disorder. This study is the first to investigate the effects of antipsychotic addition on cognitive functioning in obsessive-compulsive disorder patients. Cognitive functioning was evaluated at baseline and at endpoint of an 8-week double-blind, placebo-controlled quetiapine addition trial. Neurocognitive performance was compared between the placebo and quetiapine group and between responders and nonresponders. The neuropsychological test battery consisted of the national adult reading test, the Wisconsin Card Sorting Test, the Trail Making Test, verbal fluency, the Stroop Color Word Test, the California Verbal Learning Test, the Rey Complex Figure Task, the Continuous Performance Test, and the Digit Symbol Substitution. The results of this study suggest that quetiapine addition to serotonin reuptake inhibitors has no major effects on cognitive functioning in obsessive-compulsive disorder patients, apart from some evidence for a failure to maintain set on the Wisconsin Card Sorting Test. It is proposed that this failure may be caused by attention difficulties owing to somnolence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine and the regulation of cognition and attention
Nieoullon, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00011-4 · Cited by 1,131 · cited 1×
“Dopamine plays a pivotal role in cognitive functioning, more specifically in executive functioning and attention (Nieoullon, 2002).”
BackgroundChamberlain, S. R., Blackwell, A. D., Fineberg, N. A., Robbins, T. W., & Sahakian, B. J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.11.006 · Cited by 830 · cited 1×
“It has been shown consistently with single photon emission computed tomography and functional magnetic resonance imaging that pharmacotherapy causes a normalization of hyperactivity in frontal regions (Saxena et al., 1999; Rauch et al., 2002; Chamberlain et al., 2005).”
BackgroundCornblatt, B. A., Risch, N. J., Faris, G., Friedman, D., & Erlenmeyer-Kimling, L. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90076-5 · Cited by 682
McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.794 · Cited by 571 · cited 1×
“…1995; McDougle et al., 1995; Ravizza et al., 1996; Saxena et al., 1996; Stein et al., 1997; Pfanner et al., 2000) and four placebo-controlled (McDougle et al., 2000; Hollander et al., 2003; Li et al., 2005; Buchsbaum et al., 2006) studies have reported on risperidone, seven open (Weiss et…”
BackgroundTreatment non-response in OCD: methodological issues and operational definitions
Pallanti, S., Hollander, E., Bienstock, C., Koran, L., Leckman, J., Marazziti, D., Pato, M., Stein, D., Zohar, J., & International Treatment Refractory OCD Consortium (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702002900 · Cited by 416
Saxena, S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00082-2 · Cited by 379 · cited 1×
“It has been shown consistently with single photon emission computed tomography and functional magnetic resonance imaging that pharmacotherapy causes a normalization of hyperactivity in frontal regions (Saxena et al., 1999; Rauch et al., 2002; Chamberlain et al., 2005).”
BackgroundEvidence-based pharmacotherapy of obsessive-compulsive disorder
Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336
Denys, D., de Geus, F., van Megen, H. J. G. M., & Westenberg, H. G. M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0803 · Cited by 248
Self-citationBystritsky, A., Ackerman, D. L., Rosen, R. M., Vapnik, T., Gorbis, E., Maidment, K. M., & Saxena, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0418 · Cited by 220 · cited 2×
“…et al., 2000; Koran et al., 2000; Francobandiera, 2001; Crocq et al., 2002; D’Amico et al., 2003; Marazziti et al., 2005) and two placebocontrolled (Bystritsky et al., 2004; Shapira et al., 2004) on olanzapine, and five open (Denys et al., 2002; Mohr et al., 2002; Sevincok and Topuz, 2003; Misri…”
BackgroundNeural correlates of clinical symptoms and cognitive dysfunctions in obsessive–compulsive disorder
Kwon, J. S., Kim, J.-J., Lee, D. W., Lee, J. S., Lee, D. S., Kim, M.-S., Lyoo, I. K., Cho, M. J., & Lee, M. C. (2003) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(02)00104-x · Cited by 205
Cited by
Fradkin, I., Adams, R. A., Parr, T., Roiser, J. P., & Huppert, J. D. (2020) · Psychological Review · doi:10.1037/rev0000188 · Cited by 89
Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014) · Health Technology Assessment · doi:10.3310/hta18500 · Cited by 36
Vandborg, S. K., Hartmann, T. B., Bennedsen, B. E., Pedersen, A. D., Eskildsen, A., Videbech, P. B. H., & Thomsen, P. H. (2012) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.626869 · Cited by 24
Vandborg, S. K., Hartmann, T. B., Bennedsen, B. E., Pedersen, A. D., & Thomsen, P. H. (2015) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2014.981649 · Cited by 19
Metadata
- Authors
- de Geus, F., Denys, D., & Westenberg, H. G. M.
- Venue
- International Clinical Psychopharmacology
- Published
- 2007-03
- Volume
- 22
- Issue
- 2
- Pages
- 77-84
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2042363144
- Cited by
- 14
- References
- 17
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of quetiapine on cognitive functioning in obsessive???compulsive disorder. https://app.cochat.ai/papers/10.1097/yic.0b013e32801182f7
- The paper
- de Geus, F., Denys, D., & Westenberg, H. G. M. (2007). Effects of quetiapine on cognitive functioning in obsessive???compulsive disorder. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0b013e32801182f7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.